Overview

ATP in Alzheimer Disease

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
To Check whether systemic treatment with ATP alters the profile of cerebral metabolism in patients with Alzheimer's disease using MRS techniques (Magnetic Resonance Spectroscopy) and adjust the infusion (minimum effective dose) that promotes this metabolic change.
Phase:
Phase 2
Details
Lead Sponsor:
Sara Varea
Treatments:
Adenosine